While previous trials have linked intensive statin therapy with an increased risk of diabetes [31], our meta-analyses did not show any significant increased risk of diabetes after lowering LDL-C significantly with PCSK9 inhibitors. The gene discussed is PCSK9; the disease is diabetes mellitus.